Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Use of Water Jet for Initial Treatment FOR Peri-Implant Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2012 by Rambam Health Care Campus.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT01509898
First received: January 1, 2012
Last updated: January 12, 2012
Last verified: January 2012

January 1, 2012
January 12, 2012
November 2011
May 2012   (final data collection date for primary outcome measure)
Probing depth [ Time Frame: one month ] [ Designated as safety issue: No ]
Probing depth around the implant
Same as current
Complete list of historical versions of study NCT01509898 on ClinicalTrials.gov Archive Site
Bleeding on probing [ Time Frame: one month ] [ Designated as safety issue: No ]
Bleeding on probing (BOP) around the implant
Same as current
Not Provided
Not Provided
 
The Use of Water Jet for Initial Treatment FOR Peri-Implant Disease
The Use of Water Jet for Initial Treatment FOR Peri-Implant Disease

The aim of this study was to evaluate the effect of a dental water jet on initial peri-implant disease resolution.

Peri-implant disease is becoming more frequent during the last decade. Till today, there is no effective evidence-based treatment. The use of water-jet might improve those situations and reduce morbidity and implant loss.

Interventional
Phase 1
Phase 2
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Peri-implantitis
Device: Water jet
use of water jet for a month
Other Name: silonit water jet
Experimental: water-Jet
use of water jet for 1 month
Intervention: Device: Water jet
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
40
July 2012
May 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Signed and dated Informed Consent Form.
  • Patient suffer from peri- implant disease
  • Age Eligible for study: 18 year old and older
  • Genders Eligible for study: Both

Exclusion Criteria:

  • Patient substantially fails to comply with the study schedule, or treatment program as described in this Protocol.
Both
18 Years and older
No
Contact: Dr. liran Levin, DMD +972502062820 l_levin@rambam.health.gov.il
Israel
 
NCT01509898
0374-11-RMB
No
Rambam Health Care Campus
Rambam Health Care Campus
Not Provided
Study Director: Dr. Liran Levin, DMD Department of periodontology
Rambam Health Care Campus
January 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP